학술논문
Measurable Residual Disease (MRD) Monitoring in Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1) RUNX1-RUNX1T1 Identifies Patients at High Risk of Relapse: Results of the AML Study Group (AMLSG)
Document Type
Abstract
Author
Rücker, Frank G. ; Agrawal, Mridul ; Corbacioglu, Andrea ; Weber, Daniela ; Kapp-Schwoerer, Silke ; Gaidzik, Verena I.; Jahn, Nikolaus ; Schroeder, Thomas ; Wattad, Mohammad; Lübbert, Michael; Koller, Elisabeth ; Kindler, Thomas ; Götze, Katharina; Ringhoffer, Mark ; Westermann, Jörg ; Fiedler, Walter; Horst, Heinz A.; Greil, Richard; Schroers, Roland ; Mayer, Karin ; Heinicke, Thomas ; Krauter, Jürgen ; Schlenk, Richard F.; Thol, Felicitas; Heuser, Michael ; Ganser, Arnold; Bullinger, Lars; Paschka, Peter; Döhner, Hartmut; Döhner, Konstanze
Source
In Blood 13 November 2019 134 Supplement 1:2740-2740
Subject
Language
ISSN
0006-4971